CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 2/3, Prospective, Randomized, Multi-center, Open-Label, Controlled Trial to Assess the Efficacy & Safety of Cellular Immunotherapy With MDR-102 for Induction of Immune Quiescence™in Recipients of HLA-mismatched, LD Kidney Transplants

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03605654
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:27.971268+00:00
Published At: 2024-06-07T00:00:00+00:00
Record Updated At: 2024-06-07
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Kidney Transplant Rejection"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-06-07"
protocolSection.identificationModule.nctId: "NCT03605654"
protocolSection.identificationModule.officialTitle: "A Phase 2/3, Prospective, Randomized, Multi-center, Open-Label, Controlled Trial to Assess the Efficacy \u0026 Safety of Cellular Immunotherapy With MDR-102 for Induction of Immune Quiescence\u2122in Recipients of HLA-mismatched, LD Kidney Transplants"
protocolSection.statusModule.overallStatus: "WITHDRAWN"
protocolSection.designModule.phases: ["PHASE2", "PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.